×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SABS – sab biotherapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SABS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/22
02:11 am
sabs
SAB Biotherapeutics (NASDAQ:SABS) was upgraded by analysts at Wall Stree
Medium
Report
SAB Biotherapeutics (NASDAQ:SABS) was upgraded by analysts at Wall Stree
11/17
08:06 am
sabs
SAB Biotherapeutics (NASDAQ:SABS) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
High
Report
SAB Biotherapeutics (NASDAQ:SABS) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
11/12
01:30 pm
sabs
SAB Biotherapeutics (NASDAQ:SABS) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
SAB Biotherapeutics (NASDAQ:SABS) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/7
01:15 am
sabs
SAB Biotherapeutics (NASDAQ:SABS) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
SAB Biotherapeutics (NASDAQ:SABS) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/4
08:30 am
sabs
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
Medium
Report
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
11/4
08:00 am
sabs
SAB BIO to Participate in Upcoming Investor Conferences
Medium
Report
SAB BIO to Participate in Upcoming Investor Conferences
9/20
01:09 am
sabs
SAB Biotherapeutics (NASDAQ:SABS) was upgraded by analysts at Wall Stree
Low
Report
SAB Biotherapeutics (NASDAQ:SABS) was upgraded by analysts at Wall Stree
9/19
12:31 pm
sabs
SAB Biotherapeutics (NASDAQ:SABS) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
Medium
Report
SAB Biotherapeutics (NASDAQ:SABS) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:29 pm
sabs
Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
11/14
04:24 pm
sabs
Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Woodline Partners LP
Medium
Report
Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Woodline Partners LP
11/14
06:01 am
sabs
Form 10-Q SAB Biotherapeutics, For: Sep 30
Medium
Report
Form 10-Q SAB Biotherapeutics, For: Sep 30
11/12
04:45 pm
sabs
Form 424B3 SAB Biotherapeutics,
Medium
Report
Form 424B3 SAB Biotherapeutics,
10/3
04:31 pm
sabs
Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
High
Report
Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
10/3
04:26 pm
sabs
Form SCHEDULE 13D SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13D SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
10/3
04:06 pm
sabs
Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Commodore Capital LP
High
Report
Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Commodore Capital LP
10/1
04:35 pm
sabs
Form 4 SAB Biotherapeutics, For: Sep 29 Filed by: Moin Andrew
Medium
Report
Form 4 SAB Biotherapeutics, For: Sep 29 Filed by: Moin Andrew
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: